Epstein Becker Green’s article “Volume of Health-Care Deals Remains at Record Pace for 2021,” co-authored by Gary W. Herschman, Anjana D. Patel, and Zachary S. Taylor, attorneys in the Health Care & Life Sciences practice, in the firm’s Newark office, was cited in Fierce Healthcare.
Following is an excerpt:
Healthcare merger and acquisition activity hit a new stride in 2021, fueled by investor interest in digital health and virtual care as well as the SPAC craze that's pumping a lot of cash into the market.
M&A in the healthcare industry has been more robust than anticipated, with over 3,000 total transactions expected by year-end. That represents an increase of more than 25% as compared to 2020, according to law firm Epstein Becker & Green.
The law firm and health industry financial/investment analysts at KPMG and FocalPoint Partners predict a record year for healthcare deals in 2021, with many deals set to close by the end of the year amid uncertainty around tax rate changes and high valuations in the current market.
Announced and closed deals through the first three quarters of 2021 already exceed the total deal volume for all of 2020. At the current pace, deal volume for 2021 will easily exceed 2,750 and may traverse the 3,000 deal mark, according to Epstein Becker Green, KPMG and FocalPoint Partners.